# CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial

Study · id `cardio:ct-nct03455725` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03455725](<https://clinicaltrials.gov/study/NCT03455725>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT03455725

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 343 participants.

## Technical summary

Registry record NCT03455725. Randomized; quadruple masking; primary purpose treatment. Start 2021-06-30 (actual); primary completion 2025-02-19 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 343 participants (planned count; ClinicalTrials.gov record NCT03455725, source copy `cardio:ctgov-nct03455725-2026-01-06`, retrieved 2026-11-18)
- Started: 2021-06-30 (actual) (ClinicalTrials.gov record NCT03455725, source copy `cardio:ctgov-nct03455725-2026-01-06`, retrieved 2026-11-18)
- Primary completion: 2025-02-19 (actual) (ClinicalTrials.gov record NCT03455725, source copy `cardio:ctgov-nct03455725-2026-01-06`, retrieved 2026-11-18)
- Completion: 2027-12 (anticipated) (ClinicalTrials.gov record NCT03455725, source copy `cardio:ctgov-nct03455725-2026-01-06`, retrieved 2026-11-18)
- Countries: United States (ClinicalTrials.gov record NCT03455725, source copy `cardio:ctgov-nct03455725-2026-01-06`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03455725-2026-01-06`, retrieved 2026-11-18)

## The registry's words

- Brief title: CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial
- Acronym: CardiAMP-CMI
- Condition: Refractory Angina
- Condition: Chronic Myocardial Ischemia
- Intervention (Device): CardiAMP Cell Therapy System
- Intervention (Other): Sham Treatment
- Lead sponsor: BioCardia, Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Angina pectoris (`cardio:angina-pectoris`)

## Provenance

Content hash: 798fb1d462dcdd14597b741b544a47425a6a2bb0f8296355e09caed8246858bf
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
